Aktis Oncology, Inc.
AKTS$1.33B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaBOSTON
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jun 29, 2026
10dMarket Overview
Stock performance and key metrics
AKTS News
Catalyst Timeline
2 upcoming, 1 past
EarningsNext
AKTS Earnings Report
Jun 29, 2026Confirmed
EPS Est: $-0.31 | FQ end 2026-03
1 more catalyst beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
Drug Pipeline
No drugs found in this phase.
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply